Epigenetic regulatory roles of Mll4 in palate development

Mll4 在上颚发育中的表观遗传调控作用

基本信息

项目摘要

PROJECT SUMMARY Each year in the United States, more than 2,500 babies are born with a cleft palate (CP). CP is caused by disruption of palatogenesis during embryonic development. This proposal aims to delineate critical molecular pathways of palatogenesis, which will lead to development of better methods for diagnosis, treatment and prevention of issues associated with CP. MLL4 (aka KMT2D) is a histone H3-lysine 4 methyltransferase that creates transcriptionally active open chromatin marks. Together with other subunits, such as UTX (aka KDM6A), MLL4 forms a complex (MLL4-C), which functions as an important “epigenetic” transcriptional coactivator that triggers cell type-specific target gene expression. Mutations in the MLL4 gene, as well as the UTX gene, cause the human developmental disorder Kabuki syndrome (KS), which is characterized by craniofacial abnormalities, including CP. We discovered that conditional knockout (cKO) mice with neural crest cell (NCC)-specific deletion of Mll4 develop various KS-like craniofacial phenotypes, including 100% penetrance for CP. These results suggest that the loss of cell autonomous actions of MLL4 in the developing palatal mesenchyme results in CP and other craniofacial structural defects of KS. Thus, we hypothesize that dysregulation of the MLL4-C-dependent gene regulatory program leads to developmental and cellular deficits during palate development, resulting in CP observed in Mll4-cKO mice and human KS. To test our hypothesis, we will pursue two specific aims: Aim 1, to characterize the phenotype of cleft palate defect in Mll4-deficient mice; Aim 2, to define the mechanisms by which Mll4-C regulates palatogenesis. Building on our strong preliminary data from a unique mouse model that develops CP with 100% penetrance, this proposal will greatly advance our understanding of palatogenesis and CP pathogenesis..
项目总结 在美国,每年有超过2500名婴儿出生时患有腭裂(CP)。CP是由以下原因引起的 胚胎发育过程中腭部发育的中断。这项提案旨在描绘关键分子 腭裂发生的途径,这将导致更好的诊断、治疗和治疗方法的发展 预防与CP相关的问题。 MLL4(又名KMT2D)是一种组蛋白H3-赖氨酸4甲基转移酶,能产生转录活性的Open 染色质痕迹。MLL4与其他亚基如UTX(又名KDM6A)一起形成络合物(MLL4-C), 它是一个重要的“表观遗传”转录辅助激活因子,可触发特定细胞类型的靶标 基因表达。MLL4基因和UTX基因的突变导致人类发育 无序性歌舞伎综合征(KS),以头面部异常为特征,包括CP。 我们发现,条件基因敲除(CKO)小鼠具有神经脊细胞(NCC)特异性的MLL4缺失 形成各种KS样头面部表型,包括100%的CP外显率。这些结果表明 在发育中的腭间充质中MLL4的细胞自主作用的丧失导致CP和 KS的其他头面部结构缺陷。因此,我们假设MLL4-C依赖的调节失调 基因调控程序导致腭部发育过程中的发育和细胞缺陷,导致 在MLL4-CKO小鼠和人KS中观察到CP。为了验证我们的假设,我们将追求两个具体目标:目标1, 鉴定MLL4基因缺陷小鼠的腭裂表型;目的2,通过以下方法确定其机制 其中MLL4-C调控着腭裂的发生。建立在我们来自独特的老鼠模型的强大初步数据的基础上 这一建议将极大地促进我们对腭裂发生和发展的了解 CP病机..

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hyuk Jae Edward Kwon其他文献

Hyuk Jae Edward Kwon的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hyuk Jae Edward Kwon', 18)}}的其他基金

Genomic and functional investigations of the transcriptional regulatory network of tooth enamel development
牙釉质发育转录调控网络的基因组和功能研究
  • 批准号:
    10720303
  • 财政年份:
    2023
  • 资助金额:
    $ 15.95万
  • 项目类别:
Epigenetic regulatory roles of Mll4 in palate development
Mll4 在上颚发育中的表观遗传调控作用
  • 批准号:
    10289139
  • 财政年份:
    2021
  • 资助金额:
    $ 15.95万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 15.95万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 15.95万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.95万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.95万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 15.95万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.95万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 15.95万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 15.95万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 15.95万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 15.95万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了